Atlas Trials

A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease

Clinical trial NCT02367183 · COMPLETED

Trial details

NCT number
NCT02367183
Sponsor
Celgene
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Crohn Disease
Start date
2015-04-08
Primary completion
2016-09-06
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.